| 273 |
Mitochondrial complex inhibition leading to liver injury |
Wanda van der Stel |
BY-SA |
8 MIEs
|
2 AOs
|
|
|
| 274 |
Histone deacetylase inhibition leads to impeded craniofacial development |
Marvin Martens |
BY-SA |
1502: Histone deacetylase inhibition
|
1559: Facial cartilage structures are reduced in size and morphologically distorted
|
|
|
| 275 |
Histone deacetylase inhibition leads to neural tube defects |
Marvin Martens |
BY-SA |
1502: Histone deacetylase inhibition
|
1561: Neural tube defects
|
|
|
| 276 |
Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome |
Marvin Martens |
BY-SA |
888: Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)
|
1564: Chemical induced Fanconi syndrome
|
|
|
| 277 |
Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response |
Takao Ashikaga |
BY-SA |
1700: Impaired IL-1R1 signaling in T cell
|
984: Impairment, T-cell dependent antibody response
|
WPHA/WNT Endorsed |
1.48 |
| 278 |
IKK complex inhibition leading to liver injury |
Nanette Vrijenhoek |
BY-SA |
1574: Inhibition, IKK complex
|
2 AOs
|
|
|
| 279 |
Microtubule interacting drugs lead to peripheral neuropathy |
Marvin Martens |
BY-SA |
1580: Binding of microtubule stabilizing agents (MSA) to microtubules
|
1583: Sensory axonal peripheral neuropathy
|
|
|
| 280 |
α-diketone-induced bronchiolitis obliterans |
Marvin Martens |
BY-SA |
1584: Interaction of α-diketones with arginine residues
|
1588: Bronchiolitis obliterans
|
|
|
| 281 |
Acetylcholinesterase Inhibition Leading to Neurodegeneration |
Karen Watanabe |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
352: N/A, Neurodegeneration
|
|
|
| 282 |
Adverse outcome pathway on photochemical toxicity initiated by light exposure |
Satomi Onoue |
BY-SA |
1115: Increase, Reactive oxygen species
|
1599: Inflamatory events in light-exposed tissues
|
Under Review |
1.49 |
| 283 |
L-type calcium channel blockade leading to hypotension |
Luigi Margiotta-Casaluci |
All rights reserved |
None
|
None
|
Under Development |
1.45 |
| 284 |
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease |
Frederic Y. Bois |
BY-SA |
1487: Binding, Thiol/seleno-proteins involved in protection against oxidative stress
|
1603: Chronic kidney disease
|
|
|
| 285 |
Inhibition of N-linked glycosylation leads to liver injury |
Marvin Martens |
BY-SA |
1604: Inhibition of N-linked glycosylation
|
1549: Liver Injury
|
|
|
| 286 |
Mitochondrial complex III antagonism leading to growth inhibition (1) |
You Song |
BY-SA |
1542: Inhibition, Mitochondrial complex III
|
1521: Decrease, Growth
|
|
|
| 287 |
Mitochondrial complex III antagonism leading to growth inhibition (2) |
You Song |
BY-SA |
1542: Inhibition, Mitochondrial complex III
|
1521: Decrease, Growth
|
|
|
| 288 |
Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals) |
Bérénice COLLET |
BY-SA |
1609: Inhibition, Cytochrome P450 enzyme (CYP17A1) activity
|
1616: Malformation, cryptorchidism - maldescended testis
|
|
|
| 289 |
Inhibition of 5α-reductase leading to impaired fecundity in female fish |
Young Jun Kim |
BY-SA |
1617: Inhibition, 5α-reductase
|
360: Decrease, Population growth rate
|
Under Development |
1.81 |
| 290 |
Mitochondrial ATP synthase antagonism leading to growth inhibition (1) |
You Song |
BY-SA |
1785: Increase, Mitochondrial ATP synthase antagonism
|
1521: Decrease, Growth
|
|
|
| 291 |
Mitochondrial ATP synthase antagonism leading to growth inhibition (2) |
You Song |
BY-SA |
1785: Increase, Mitochondrial ATP synthase antagonism
|
1521: Decrease, Growth
|
|
|
| 292 |
Inhibition of tyrosinase leads to decreased population in fish |
Young Jun Kim |
BY-SA |
1627: Inhibition of tyrosinase
|
360: Decrease, Population growth rate
|
Under Development |
1.78 |
| 293 |
Increased DNA damage leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1194: Increase, DNA damage
|
3 AOs
|
Under Development |
1.80 |
| 294 |
Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1632: Increase in reactive oxygen and nitrogen species (RONS)
|
4 AOs
|
Under Development |
1.80 |
| 295 |
Early-life stromal estrogen receptor activation by endocrine disrupting chemicals in the mammary gland leading to enhanced cancer risk |
Andrea Hindman |
BY-SA |
None
|
None
|
Under Development |
1.79 |
| 296 |
Oxidative DNA damage leading to chromosomal aberrations and mutations |
Carole Yauk |
BY-SA |
1634: Increase, Oxidative DNA damage
|
2 AOs
|
WPHA/WNT Endorsed |
1.76 |
| 297 |
Inhibition of retinaldehyde dehydrogenase leads to population decline |
Young Jun Kim |
BY-SA |
1637: Retinaldehyde dehydrogenase inhibition
|
360: Decrease, Population growth rate
|
Under Development |
1.77 |